Extracorporeal norepinephrine filtration is associated with increasing norepinephrine requirements during percutaneous hepatic perfusion with melphalan
Chemosaturation with percutaneous hepatic perfusion (CS-PHP) using melphalan is frequently associated with profound hypotension, necessitating high-dose norepinephrine support. We investigated the potential of the extracorporeal chemofilter to remove circulating norepinephrine. In this prospective observational study, paired blood samples were obtained upstream and downstream of the extracorporeal filter during CS-PHP at predefined procedural timepoints. Norepinephrine was quantified using liquid chromatography–tandem mass spectrometry. Transfilter concentration reduction was assessed in conjunction with temporal changes in norepinephrine administration during the procedure. A total of ten CS-PHP procedures in eight patients were analyzed. This included the main test, for which one procedure was performed on each patient (n = 8), as well as an additional test on one patient, for which two additional procedures were performed to enable an intra-individual assessment of three consecutive procedures. Circulating norepinephrine concentrations increased during treatment, peaking upstream of the filter during active filtration. The filter reduced norepinephrine concentrations by a median of 91.3% after bypass closure and 91.9% during melphalan perfusion (both p = 0.008). Norepinephrine infusion rates increased from a median of 0.2 μg/kg/min after inferior vena cava occlusion to 0.6 μg/kg/min immediately after filter activation ( p < 0.01). These rates remained elevated throughout filtration before decreasing after completion of the procedure. The temporal relationship between transfilter concentration reduction of norepinephrine and a significant increase in norepinephrine administration suggests an association with hemodynamic effects during CS-PHP.
Authors
- Holger Gößmann
- Mirko Peitzsch (ORCID: https://orcid.org/0000-0002-2472-675X)
- Sebastian Ebel (ORCID: https://orcid.org/0000-0001-6856-6455)
- Madlen Matz‐Soja (ORCID: https://orcid.org/0000-0002-5929-3704)
- Denis Bösemann
- Holger Kirsten (ORCID: https://orcid.org/0000-0002-3126-7950)
- Conrad Hempel (ORCID: https://orcid.org/0000-0001-9885-7165)
- Timm Denecke (ORCID: https://orcid.org/0000-0003-3313-3208)
- Manuel Florian Struck (ORCID: https://orcid.org/0000-0002-0070-3406)
- Florian van Bömmel (ORCID: https://orcid.org/0000-0003-2679-0672)
- Thomas Berg (ORCID: https://orcid.org/0000-0003-0003-6241)
Institutions
- Zimmer Biomet (Netherlands) (NL)
- University Hospital Leipzig (DE)
- Jena University Hospital (DE)
- University Hospital Carl Gustav Carus (DE)
- Technische Universität Dresden (DE)
- Leipzig University (DE)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1038/s41598-026-81132-6
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00